Products
Manufacturing Services
Quality
Knowledge Center
About Us
Products
Cytokines, Growth Factors, & Nucleases
Human Plasma Derived Products
Media & Media Supplements
Closed System Solutions™ (CSS) line of cGMP Products
Quality
Quality at Akron
Master Files
Manufacturing Services
Plasmid DNA & Endonucleases
Proteins
Media & Buffers
Transfection & Transduction Reagents
Knowledge Center
Blog
Past Events
Posters & Publications
Knowledge Center
Blog
Past Events
Posters & Publications
About Us
The Akron Difference
Partnerships
Executive Leadership
Scientific Advisory Board
Newsroom
Upcoming Events
About Us
The Akron Difference
Partnerships
Executive Leadership
Scientific Advisory Board
Newsroom
Upcoming Events
Careers
Contact Us
Products
Products
Cytokines, Growth Factors, & Nucleases
Human Plasma Derived Products
Media & Media Supplements
Closed System Solutions™ (CSS) line of cGMP Products
Manufacturing Services
Manufacturing Services
Plasmid DNA & Endonucleases
Proteins
Media & Buffers
Transfection & Transduction Reagents
Quality
Quality
Quality at Akron
Master Files
Knowledge Center
Knowledge Center
Blog
Past Events
Posters & Publications
About Us
About Us
The Akron Difference
Partnerships
Executive Leadership
Scientific Advisory Board
Newsroom
Upcoming Events
Careers
Contact Us
Knowledge Center
Blog
All
2019
2020
2021
Showing 30 of 30 blog
May 06, 2024
Reducing the Complexity, Time, Risk, and Cost of Media Formulation in Cell Therapy Manufacturing
Read More
Feb 13, 2023
Comparable Advantages of IL-2 Ancillary Material Use Over Pharmaceutical Reagents within Cell Therapy Manufacturing
Read More
Jun 03, 2021
Mitigating unintentional effects of pharmaceutical human serum albumin preparations in therapeutic cell culture
Read More
Mar 26, 2021
Enhancing the safety of virus-inactivated ancillary materials through neutralizing antibodies
Read More
Mar 10, 2021
Going Green, the Akron Way
Read More
Feb 25, 2021
Reducing Variability in Cytokine Activity Reporting
Read More
Jan 20, 2021
Safety First: Methods of virus inactivation for increased safety of advanced therapies
Read More
Dec 16, 2020
Cryopreservation During the Holidays
Read More
May 06, 2020
Building a resilient cell and gene therapy industry in the face of COVID-19
Read More
Apr 06, 2020
The importance of cytokine and growth factor purity in cell therapy development and manufacturing
Read More
Feb 18, 2020
Building a Robust Supply Chain to Enable Cell and Gene Therapy Development
Read More
Nov 18, 2019
Superiority, Non-inferiority and Equivalence – The Phase III Question
Read More
1
2
3